Navigation Links
New Vaccines To Combat Rotavirus

Rotavirus which causes severe diarrhea can be combated with two new vaccines, according to clinical trials. The New England Journal of Medicine has published this report.// The symptoms can be reduced by as much as by between 85% to 100%. The affliction affects children in large numbers.

Experts say the unqualified success of two drugs in these larger trials, without negative side effects, is a major step towards getting them put into wider use. Researchers hope that the vaccines, which are swallowed rather than injected, will become a routine part of the immunization repertoire given to babies alongside diphtheria and tetanus.

"These results are really promising and very exciting," Nature quoted Umesh Parashar, an infectious-disease specialist in Georgia, as saying.

To prove that the new vaccines are safe, the teams enrolled more than 60,000 infants for each trial, in order to detect complications that might develop in only a few tens or hundreds.

Both vaccines appeared to avoid side effects and protected children against multiple strains of rotavirus. One, called Rotarix and manufactured by drug giant GlaxoSmithKline, contains a crippled strain of live human rotavirus1. The other, a Merck vaccine dubbed RotaTeq, is made up of five different disabled rotaviruses, each a combination of strains from humans and cows.

Researchers add that they must perform additional clinical trials to test whether the immunizations are as effective on children that are malnourished and harbor other infections, as is often the case in developing countries. The vaccine may also prove too expensive for widespread use in such places.

Edited (ANI)
'"/>




Page: 1

Related medicine news :

1. Producing Vaccines from genetically modified crops
2. Understanding Chronic Infections May Help in Developing Therapeutic Vaccines
3. New Anthrax Vaccines Will Take time
4. Success Of Preventable High-Risk HPV Infections With Vaccines May Vary
5. Health and Human Services stockpiles 20 million bird flu Vaccines
6. Chiron Corporation Gets US Contract To Produce Bird Flu Vaccines
7. Oral Edible vaccine for Allergy Vaccines
8. South Africa May Start Manufacturing Bird Flu Vaccines
9. Ranbaxy Laboratories All Set To Export Bird Flu Vaccines
10. From Computers to Vaccines
11. India To Produce More Cost Effective Vaccines
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/16/2017)... ... ... Maury Regional Health has announced a large-scale adoption of AccuVein vein visualization ... Regional Medical Center is making vein visualization part of their standard of care. , ... importantly, helps our staff members locate a vein that will provide good access to ...
(Date:8/16/2017)... ... August 16, 2017 , ... A global leader in the treatment ... clinics in all 29 Indian states—bringing the country one step closer to eliminating clubfoot ... the nonprofit organization is on track to enroll 10,000 children in the clubfoot treatment ...
(Date:8/16/2017)... ... , ... Fusion Flix Inc., a Telly Award Winning, Non Profit Corporation has ... viewers in a partnership with the Amazon Video Direct Streaming Distribution Platform. , Their ... Ray disc in 2018. Proceeds will be going to further health research. , ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... TopConsumerReviews.com recently ... Lab Testing . , The healthcare industry in the United States has undergone ... are the days of needing to have a doctor’s order to get a blood ...
(Date:8/16/2017)... , ... August 16, 2017 , ... First Choice ... States, named Dr. Douglas J. Harrison, as the new Medical Director of its Sienna ... new facility Medical Director of our Sienna Plantation location,” said Dr. Michael (Derek) Caraway, ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... , Aug. 15, 2017  AOTI Inc. announced today that its ... Inc., has recently opened a New York City Office in ... of its unique Topical Wound Oxygen (TWO 2 ) homecare therapy. ... Accreditation Commission for Health Care (ACHC) under the company,s DMEPOS accreditation ... ...
(Date:8/8/2017)... Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today reports its financial results for the second quarter ... during the second quarter 2017 and to date: ... clinical development programs for the Company,s lead project, BL-8040: ... pivotal study with BL-8040 as novel stem cell mobilization ...
(Date:8/7/2017)... Mich. , Aug. 7, 2017 Diplomat Pharmacy, ... of Joel Saban as president, effective Aug. 7, ... Urick has decided to pursue other interests and will ... "During his tenure, Paul has served us in multiple leadership ... Specialty Pharmacy in Jun. 2015 and has provided decisive, strategic ...
Breaking Medicine Technology: